Advertisement
UK markets open in 5 hours 50 minutes

  • NIKKEI 225

    38,295.56
    +743.40 (+1.98%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.46
    +0.10 (+0.12%)
     

  • GOLD FUTURES

    2,333.80
    -8.30 (-0.35%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,608.27
    -214.12 (-0.40%)
     

  • CMC Crypto 200

    1,435.48
    +20.72 (+1.47%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Insights on the Radiotherapy Market to 2028 - by Type, Product, Application, End-user and Geography

Research and Markets
·9-min read

Dublin, Aug. 24, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product, Application, and End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The radiotherapy market was valued at US$ 6,474.78 million in 2020 and it is projected to reach US$ 10,170.80 million by 2028; it is expected to grow at a CAGR of 5.80% from 2020 to 2028. The growth of the market is attributed to a few key driving factors such as increasing prevalence of cancer and rising number of conferences and symposiums to boost the awareness about radiation therapy. However, increased risk of adverse effects due to radiation therapy restrains the market growth.

Health systems across the globe are witnessing substantial increase in the prevalence of cancer. According to the data published by the World Health Organization (WHO), in 2019, around 9.6 million deaths were caused by cancer across the globe. Moreover, according to the same data, prostate, lung, colorectal, liver, and stomach cancer are most observed in men, while breast, colorectal, and cervical cancer are the most common among women. Furthermore, according to a study published by the National Cancer Institute, in 2021, the incidence of Cancer in the US is likely to reach 1.9 million. In addition, around 0.6 million people are anticipated to die during 2021 in the US due to cancer.

Moreover, according to a data published by the Cancer Research UK in 2020, around 0.16 million people in the UK die each year due to cancer. Moreover, as per the Globocan report, in 2018, there were 911,014 breast cancer cases and 310,577 deaths due to breast cancer, of which 367,900 and 162,468 breast cancer cases were reported in China and India, respectively. Such high prevalence of cancer is anticipated to drive the adoption of radiotherapy. For instance, according to a data published by the WHO in March 2021, over 50% of cancer patients involve radiotherapy as part of cancer management and care. Moreover, according to the same data, radiotherapy is prominently used to treat the most common types of cancer such as breast, cervical, colorectal, and lung cancer. This factor ultimately boosts the growth of the global radiotherapy market.

The radiotherapy market is expected to witness substantial growth after the COVID-19 pandemic. Delayed or rescheduled radiation therapy treatments and new cancer cases are anticipated to have positive impact on the market growth post-pandemic.

Based on type, the radiotherapy market is segmented into external-beam radiation therapy, internal radiation therapy, and systemic radiotherapy/radiopharmaceuticals. The external-beam radiation therapy segment held the largest market share in 2020, and it is estimated to register the highest CAGR from 2021 to 2028.

The radiotherapy market, based on product, is segmented into external beam radiotherapy products internal radiotherapy products, radiotherapy software, and others. The external-beam radiotherapy product segment held the largest market share in 2020, and the same segment is estimated to register the highest CAGR during the forecast period.

Based on application, the radiotherapy market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, liver cancer, thyroid cancer, lymphoma, spine cancer, brain cancer, and others. The breast cancer segment held the largest market share in 2020, and the lung cancer segment is estimated to register the highest CAGR during 2021-2028.

In terms of end user, the radiotherapy market is segmented into hospitals, specialty clinics, and radiation therapy centers. The hospitals segment held the largest share of the market in 2020, and it is further estimated to register the highest CAGR during the forecast period.

Key Topics Covered:

1. Introduction

2. Radiotherapy Market - Key Takeaways

3. Research Methodology

4. Global Radiotherapy Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.1 Expert Opinions

5. Radiotherapy Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer Worldwide
5.1.2 Increasing Number of Conferences and Symposiums to Boost Awareness About Radiation Therapy
5.2 Market Restraints
5.2.1 Increased Risk of Adverse Effects due to Radiation Therapy
5.3 Market Opportunities
5.3.1 Cancer Screening Programs and Implementation of Standard Guidelines
5.4 Future Trends
5.4.1 Emphasis on Reduced Radiation Exposure Therapies
5.5 Impact Analysis

6. Radiotherapy Market - Global Analysis
6.1 Global Radiotherapy Market Revenue Forecast And Analysis
6.2 Global Radiotherapy Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Radiotherapy Market Analysis - By Type
7.1 Overview
7.2 Radiotherapy Market Revenue Share, by Type (2020 and 2028)
7.3 External-Beam Radiation Therapy
7.3.1 Overview
7.3.2 External-Beam Radiation Therapy: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Internal Radiation Therapy
7.4.1 Overview
7.4.2 Internal Radiation Therapy: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Systemic Radiotherapy/Radiopharmaceuticals
7.5.1 Overview
7.5.2 Radiotherapy/Radiopharmaceuticals: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)

8. Radiotherapy Market Analysis - By Product
8.1 Overview
8.2 Radiotherapy Market Revenue Share, by Product (2020 and 2028)
8.3 External Beam Radiotherapy Products
8.3.1 Overview
8.3.2 External Beam Radiotherapy Products: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Internal Radiotherapy Products
8.4.1 Overview
8.4.2 Internal Radiotherapy Products: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Radiotherapy Software
8.5.1 Overview
8.5.2 Radiotherapy Software: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)

9. Radiotherapy Market Analysis - By Application
9.1 Overview
9.2 Radiotherapy Market Revenue Share, by Application (2020 and 2028)
9.3 Breast Cancer
9.3.1 Overview
9.3.2 Breast Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Lung Cancer
9.4.1 Overview
9.4.2 Lung Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Prostate Cancer
9.5.1 Overview
9.5.2 Prostate Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Colorectal Cancer
9.6.1 Overview
9.6.2 Colorectal Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Lymphoma
9.7.1 Overview
9.7.2 Lymphoma: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Liver Cancer
9.8.1 Overview
9.8.2 Liver Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Thyroid Cancer
9.9.1 Overview
9.9.2 Thyroid Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Brain Cancer
9.10.1 Overview
9.10.2 Brain Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.11 Cervical Cancer
9.11.1 Overview
9.11.2 Cervical Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.12 Spine Cancer
9.12.1 Overview
9.12.2 Spine Cancer: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.13 Others
9.13.1 Overview
9.13.2 Others: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)

10. Radiotherapy Market Analysis - By End User
10.1 Overview
10.2 Radiotherapy Market Share, by End User, 2020 and 2028, (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Radiation Therapy Centres
10.4.1 Overview
10.4.2 Radiation Therapy Centres: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
10.5.1 Overview
10.5.2 Specialty Clinics: Radiotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11. Radiotherapy Market - Geographic Analysis

12. Impact of COVID-19 Pandemic on Global Radiotherapy Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
12.2 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.3 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic

13. Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview

14. Company Profiles
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Accuray Incorporated
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sumitomo Heavy Industries, Ltd.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Elekta AB
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Hitachi, Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Brainlab AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 PROTOM INTERNATIONAL
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Varian Medical Systems, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Maastro
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Mevion Medical Systems
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/s9radw

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900